Kyowa Kirin GmbH (batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of respiratory distress syndrome (RDS) or hyaline membrane disease in newborns. It is also used for prophylaxis in preterm infants at risk of developing RDS or with established surfactant deficiency.
Dosage form: suspension, endotracheal
Active substance Dosage phospholipid fraction isolated from pig lungs 80 mg/ml ATC: R07AA02
-
The drug is indicated for the treatment of apnea of prematurity (pauses in breathing) in preterm infants.
Dosage form: solution for infusion and oral use
Active substance Dosage caffeine 10 mg/ml ATC: N06BC01